100 Years, 100 Breakthrough T1D Scientists: The BB Rat—An Animal Model of Type 1 Diabetes
In 1974, a colony of non-diabetic BB rats develops diabetes. Examination of their pancreases revealed that they had no beta…
The First Gene-Edited Cell Replacement Therapy Takes a Step Forward
The first person has received ViaCyte and CRISPR's cell replacement therapy.
FDA Authorizes a Fourth Artificial Pancreas System
The FDA authorized the Insulet Omnipod 5, the world’s first tubeless, wearable system for people 6 and older, using an…
Interview with our New Community Screening and Clinical Trial Education Director
Breakthrough T1D has a new community screening and clinical trials education director. She's been a volunteer and now staff since…
New Study Shows Kids 1+ Benefit from Artificial Pancreas Technology
A new paper published in the New England Journal of Medicine shows hybrid closed loop systems help children as young…
100 Years, 100 Breakthrough T1D Scientists: Gian Franco Bottazzo, M.D.
In honor of the 100th anniversary of insulin, we are launching “100 Years, 100 Breakthrough T1D Scientists.” The first up:…
Rufus, the Bear with Diabetes®, “2.0”
He’s cute. He’s fuzzy and cuddly. And thanks to the Breakthrough T1D-Beyond Type 1 Alliance, Rufus, the Bear with Diabetes®…
CDC Study: Children Who Have Recovered from COVID-19 May Be at Increased Risk of Diabetes
CDC researchers report an apparent association between pediatric COVID-19 and diabetes diagnoses.
Insulin: A Story of Innovation
On January 11, 1922—100 years ago—14-year-old Leonard Thompson, who was diagnosed with diabetes 3 years earlier, became the first person…
